A role for D1 dopamine receptors in striatal methamphetamine-induced neurotoxicity

Neuroscience Letters

Volumn 555, Issue , 2013, Pages 243-247

  Friend, Danielle M ^a   Keefe, Kristen A ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE; METHAMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BODY TEMPERATURE; CONTINUOUS INFUSION; CONTROLLED STUDY; COOLING; CORPUS STRIATUM; HYPERTHERMIA; IMMUNOHISTOCHEMISTRY; MALE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; NOTE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

DA; DOPAMINE; DOPAMINE RECEPTOR; METH; METHAMPHETAMINE; NEUROTOXICITY; PND; POST-NATAL DAY;

ANIMALS; BENZAZEPINES; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGENTS; FEVER; HOT TEMPERATURE; MALE; METHAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1;

EID: 84887609535     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.08.039     Document Type: Note

References (26)

1. Ali S.F., Newport G.D., Holson R.R., Slikker W., Bowyer J.F. Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res. 1994, 658:33-38.
2. Ali S.F., Newport R.R., Holson W., Slikker W., Bowyer J.F. Low environmental temperatures or pharmacologic agents that produce hyperthermia decrease methamphetamine neurotoxicity in mice. Ann. N. Y. Acad. Sci. 1995, 765:338.
3. Ares-Santos S., Granado N., Oliva I., O'Shea E., Martin E.D., Colado M.I., Moratalla R. Dopamine D(1) receptor deletion strongly reduces neurotoxic effects of methamphetamine. Neurobiol. Dis. 2012, 45:810-820.
4. Bellomo M., Giuffrida R., Palmeri A., Sapienza S. Excitatory amino acids as neurotransmitters of corticostriatal projections: immunocytochemical evidence in the rat. Arch. Ital. Biol. 1998, 136:215-223.
5. Bowyer J.F., Davies D.L., Schmued L., Broening H.W., Newport G.D., Slikker W., Holson R.R. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J. Pharmacol. Exp. Ther. 1994, 268:1571-1580.
6. Broening H.W., Morford L.L., Vorhees C.V. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions. Synapse 2005, 56:84-93.
7. Callaghan R.C., Cunningham J.K., Sajeev G., Kish S.J. Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders. Mov. Disord. 2010, 25:2333-2339.
8. Callaghan R.C., Cunningham J.K., Sykes J., Kish S.J. Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs. Drug Alcohol Depend. 2012, 120:35-40.
9. Deniau J.M., Chevalier G. Disinhibition as a basic process in the expression of striatal functions. II. The striato-nigral influence on thalamocortical cells of the ventromedial thalamic nucleus. Brain Res. 1985, 334:227-233.
10. Friend D.M., Keefe K.A. Glial Reactivity in resistance to methamphetamine-induced neurotoxicity. J. Neurochem. 2013.
11. Friend D.M., Son J.H., Keefe K.A., Fricks-Gleason A.N. Expression and activity of nitric oxide synthase isoforms in methamphetamine-induced striatal dopamine toxicity. J. Pharmacol. Exp. Ther. 2013, 344:511-521.
12. Gerfen C.R. The neostriatal mosaic: striatal patch-matrix organization is related to cortical lamination. Science 1989, 246:385-388.
13. Gross N.B., Duncker P.C., Marshall J.F. Cortical ionotropic glutamate receptor antagonism protects against methamphetamine-induced striatal neurotoxicity. Neuroscience 2011, 199:272-283.
14. Gross N.B., Duncker P.C., Marshall J.F. Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity. Synapse 2011, 65:1144-1155.
15. Kaneko T., Mizuno N. Immunohistochemical study of glutaminase-containing neurons in the cerebral cortex and thalamus of the rat. J. Comp. Neurol. 1988, 267:590-602.
16. Kogan F.J., Nichols W.K., Gibb J.W. Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels. Eur. J. Pharmacol. 1976, 36:363-371.
17. Levey A.I., Hersch S.M., Rye D.B., Sunahara R.K., Niznik H.B., Kitt C.A., Price D.L., Maggio R., Brann M.R., Ciliax B.J. Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc. Natl. Acad. Sci. USA 1993, 90:8861-8865.
18. Mark K.A., Soghomonian J.J., Yamamoto B.K. High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity. J. Neurosci. 2004, 24:11449-11456.
19. McCann U.D., Kuwabara H., Kumar A., Palermo M., Abbey R., Brasic J., Ye W., Alexander M., Dannals R.F., Wong D.F., Ricaurte G.A. Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. Synapse 2008, 62:91-100.
20. Nicholson L.F., Faull R.L., Waldvogel H.J., Dragunow M. GABA and GABAA receptor changes in the substantia nigra of the rat following quinolinic acid lesions in the striatum closely resemble Huntington's disease. Neuroscience 1995, 66:507-521.
21. O'Dell S.J., Weihmuller F.B., Marshall J.F. Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists. J. Neurochem. 1993, 60:1792-1799.
22. O'Dell S.J., Weihmuller F.B., Marshall J.F. Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity. Brain Res. 1991, 564:256-260.
23. Sekine Y., Iyo M., Ouchi Y., Matsunaga T., Tsukada H., Okada H., Yoshikawa E., Futatsubashi M., Takei N., Mori N. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am. J. Psychiatry 2001, 158:1206-1214.
24. Steiner H., Kitai S.T. Regulation of rat cortex function by D1 dopamine receptors in the striatum. J. Neurosci. 2000, 20:5449-5460.
25. Timmerman W., Westerink B.H. Electrical stimulation of the substantia nigra reticulata: detection of neuronal extracellular GABA in the ventromedial thalamus and its regulatory mechanism using microdialysis in awake rats. Synapse 1997, 26:62-71.
26. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Franceschi D., Sedler M., Gatley S.J., Miller E., Hitzemann R., Ding Y.S., Logan J. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J. Neurosci. 2001, 21:9414-9418.